Latest News and Press Releases
Want to stay updated on the latest news?
-
REDWOOD CITY, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (“Graybug”), a clinical stage biopharmaceutical company focused on developing transformative medicines to treat chronic...
-
Under the terms of the research collaboration agreement, CalciMedica will use EpiPharma’s state of the art Pre-clinical Drug Testing and Diagnostics Laboratory Platform to accelerate its drug...
-
Median time to recovery was more than two times faster for patients treated with Auxora plus standard of care compared to standard of care aloneThe percentage of patients requiring invasive mechanical...
-
Robert N. Wilson was Former Johnson & Johnson Vice ChairmanBoard Member, Eric W. Roberts, named Vice Chairman and Chairman of the Strategic Transactions and Finance Committee of the Board LA...
-
Interim results showed Auxora plus standard of care improved time to recovery and reduced ventilator use in patients compared to standard of care alone LA JOLLA, Calif., May 28, 2020 (GLOBE...
-
Funds to support ongoing clinical trials in patients with COVID-19 pneumonia and commercial manufacturing of Auxora™ LA JOLLA, Calif., May 22, 2020 (GLOBE NEWSWIRE) -- CalciMedica Inc....
-
LA JOLLA, Calif., May 21, 2020 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica” or the “Company), a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC)...
-
REDWOOD CITY, Calif., May 18, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc., a clinical stage biopharmaceutical company focused on developing transformative medicines to treat vision-threatening...
-
LA JOLLA, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica” or the “Company), a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC)...
-
Phase 2 open-label study expands to additional sites across the U.S. and aims to enroll 120 patients LA JOLLA, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica” or the...